The Highest Quality CBD Oil

Meticulously sourced.
Thoughtfully produced.
100% organic.
Discover the difference.
October 19, 2018 | by Healthcare Weekly Staff

Abbott’s MitraClip for Heart Failure Patients

The Mitraclip, developed by Chicago-based Abbott Laboratories, can greatly reduce death rates in patients with severe heart failure, according to a new study published in the New England Journal of Medicine.

The tiny device inserted into the heart via a catheter greatly boosts survival rates among patients with severe heart failure. Cardiologists call the procedure “ a game changer.” The Food and Drug Administration (FDA) already approved the clip for patients too frail for surgery, but whose hearts are healthy except for a diseased mitral valve.

How Pritzker Plans To Increase Measles Vaccination Rates in Illinois
Healthcare Weekly Staff
Healthcare Weekly Staff

The Healthcare Weekly staff brings you the latest in healthcare innovation, technology, news and more.

Leave a comment

Healthcare Weekly Newsletter

Get the latest in healthcare leadership, news, and innovation.

We don’t share your contact information with any 3rd party

Contact us

Get in touch to learn how we can help


Work Email


Thank you for contacting Healthcare Weekly.

We will get in touch with you shortly.